Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target.
Leukemia. 2017 Jan;31(1):234-237. doi: 10.1038/leu.2016.249. Epub 2016 Aug 30.
Leukemia. 2017.
PMID: 27573556
Free PMC article.
No abstract available.
A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia.
Zhang M, Sukhumalchandra P, Enyenihi AA, St John LS, Hunsucker SA, Mittendorf EA, Sergeeva A, Ruisaard K, Al-Atrache Z, Ropp PA, Jakher H, Rodriguez-Cruz T, Lizee G, Clise-Dwyer K, Lu S, Molldrem JJ, Glish GL, Armistead PM, Alatrash G.
Zhang M, et al. Among authors: jakher h.
Clin Cancer Res. 2013 Jan 1;19(1):247-57. doi: 10.1158/1078-0432.CCR-12-2753. Epub 2012 Nov 12.
Clin Cancer Res. 2013.
PMID: 23147993
Free PMC article.
Item in Clipboard
Cancer immunotherapies, their safety and toxicity.
Alatrash G, Jakher H, Stafford PD, Mittendorf EA.
Alatrash G, et al. Among authors: jakher h.
Expert Opin Drug Saf. 2013 Sep;12(5):631-45. doi: 10.1517/14740338.2013.795944. Epub 2013 May 14.
Expert Opin Drug Saf. 2013.
PMID: 23668362
Review.
Item in Clipboard
Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target.
Khan M, Carmona S, Sukhumalchandra P, Roszik J, Philips A, Perakis AA, Kerros C, Zhang M, Qiao N, John LSS, Zope M, Goldberg J, Qazilbash M, Jakher H, Clise-Dwyer K, Qiu Y, Mittendorf EA, Molldrem JJ, Kornblau SM, Alatrash G.
Khan M, et al. Among authors: jakher h.
Front Immunol. 2018 Jan 25;8:1975. doi: 10.3389/fimmu.2017.01975. eCollection 2017.
Front Immunol. 2018.
PMID: 29422892
Free PMC article.
Item in Clipboard
Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.
Alatrash G, Mittendorf EA, Sergeeva A, Sukhumalchandra P, Qiao N, Zhang M, St John LS, Ruisaard K, Haugen CE, Al-Atrache Z, Jakher H, Philips AV, Ding X, Chen JQ, Wu Y, Patenia RS, Bernatchez C, Vence LM, Radvanyi LG, Hwu P, Clise-Dwyer K, Ma Q, Lu S, Molldrem JJ.
Alatrash G, et al. Among authors: jakher h.
J Immunol. 2012 Dec 1;189(11):5476-84. doi: 10.4049/jimmunol.1201221. Epub 2012 Oct 26.
J Immunol. 2012.
PMID: 23105141
Free PMC article.
Item in Clipboard
Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma.
Alatrash G, Perakis AA, Kerros C, Peters HL, Sukhumalchandra P, Zhang M, Jakher H, Zope M, Patenia R, Sergeeva A, Yi S, Young KH, Philips AV, Cernosek AM, Garber HR, Qiao N, Weng J, St John LS, Lu S, Clise-Dwyer K, Mittendorf EA, Ma Q, Molldrem JJ.
Alatrash G, et al. Among authors: jakher h.
Clin Cancer Res. 2018 Jul 15;24(14):3386-3396. doi: 10.1158/1078-0432.CCR-17-2626. Epub 2018 Apr 16.
Clin Cancer Res. 2018.
PMID: 29661776
Item in Clipboard
Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time.
Tang X, Alatrash G, Ning J, Jakher H, Stafford P, Zope M, Shpall EJ, Jones RB, Champlin RE, Thall PF, Andersson BS.
Tang X, et al. Among authors: jakher h.
Biol Blood Marrow Transplant. 2014 Aug;20(8):1139-44. doi: 10.1016/j.bbmt.2014.04.003. Epub 2014 Apr 13.
Biol Blood Marrow Transplant. 2014.
PMID: 24727332
Free PMC article.
Item in Clipboard
Canagliflozin review - safety and efficacy profile in patients with T2DM.
Jakher H, Chang TI, Tan M, Mahaffey KW.
Jakher H, et al.
Diabetes Metab Syndr Obes. 2019 Feb 1;12:209-215. doi: 10.2147/DMSO.S184437. eCollection 2019.
Diabetes Metab Syndr Obes. 2019.
PMID: 30787627
Free PMC article.
Review.
Item in Clipboard
Cite
Cite